Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Feb 22, 2022

SELL
$3.64 - $7.76 $207,596 - $442,568
-57,032 Closed
0 $0
Q1 2020

Feb 22, 2022

BUY
$4.0 - $21.53 $25,416 - $136,801
6,354 Added 12.54%
57,032 $228,000
Q4 2019

Feb 22, 2022

BUY
$13.94 - $24.12 $706,451 - $1.22 Million
50,678 New
50,678 $1.09 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $181M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Matrix Private Capital Group LLC Portfolio

Follow Matrix Private Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Private Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Private Capital Group LLC with notifications on news.